These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6869203)

  • 1. Pharmacokinetics and clinical pharmacology of indapamide.
    Caruso FS; Szabadi RR; Vukovich RA
    Am Heart J; 1983 Jul; 106(1 Pt 2):212-20. PubMed ID: 6869203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indapamide on volume-dependent hypertension, renal haemodynamics, solute excretion and proximal nephron fractional reabsorption in the dog.
    Burke TJ; Nobles EM; Wolf PS; Erickson AL
    Curr Med Res Opin; 1983; 8 Suppl 3():25-37. PubMed ID: 6617239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.
    Pruss T; Wolf PS
    Am Heart J; 1983 Jul; 106(1 Pt 2):208-11. PubMed ID: 6869202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-centre clinical investigation of indapamide in the United States: a review.
    Vukovich RA; Zisblatt M; Caruso F; Losi M; Barton J; Schotz WE; Webb E; Eff J; Bronstein R; Neiss ES
    Curr Med Res Opin; 1983; 8 Suppl 3():109-22. PubMed ID: 6352183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the acute and chronic administration of indapamide on systemic and renal haemodynamics in essential hypertension.
    Villarreal H; Nuñez-Poissot E; Anguas MC; Degandarias L; Meza U
    Curr Med Res Opin; 1983; 8 Suppl 3():135-9. PubMed ID: 6617237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology and clinical pharmacology of indapamide.
    Campbell DB; Moore RA
    Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of 14C-indapamide in man.
    Klunk LJ; Ringel S; Neiss ES
    J Clin Pharmacol; 1983; 23(8-9):377-84. PubMed ID: 6630587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
    Acchiardo SR; Skoutakis VA
    Am Heart J; 1983 Jul; 106(1 Pt 2):237-44. PubMed ID: 6346847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indapamide: a unique diuretic?
    Conner CS
    Drug Intell Clin Pharm; 1983 Dec; 17(12):898-9. PubMed ID: 6653405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats.
    Uehara Y; Kawabata Y; Shirahase H; Wada K; Hashizume Y; Morishita S; Numabe A; Iwai J
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S42-6. PubMed ID: 7508060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension.
    Pedersen EB; Danielsen H; Spencer ES
    Eur J Clin Pharmacol; 1984; 26(5):543-7. PubMed ID: 6468469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of bilateral nephrectomy on the pharmacokinetics of 14C-indapamide (REV 2555) and its metabolites in the dog.
    Klunk LJ; Mangat S; Treitman JA; Grebow PE
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):223-34. PubMed ID: 6658187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of indapamide in hypertensive patients with or without renal failure. A dose-response curve.
    Leenen FH; Smith DL; Farkas RM; Boer WH; Reeves RA; Marquez-Julio A
    Am J Med; 1988 Jan; 84(1B):76-85. PubMed ID: 3341390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
    Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
    Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of indapamide in dogs.
    Grebow PE; Treitman JA
    J Pharm Sci; 1981 Dec; 70(12):1310-2. PubMed ID: 7320842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of indapamide in essential hypertension.
    Morledge JH
    Am Heart J; 1983 Jul; 106(1 Pt 2):229-32. PubMed ID: 6346846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.